ARCHIVES

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

This article is from The Cancer Letter archive.

Vol. 15 No. 10 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011

Diet Intervention Results Could Be Found In Months

April 4, 1986

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

April 29, 1994

Senate Subcommittee Votes $970 Million for NCI In FY 1980; Magnuson Cancer Support Holds Firm

June 23, 1978

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985